Drug Shortage Report for TAMIFLU
Report ID | 39146 |
Drug Identification Number | 02381842 |
Brand name | TAMIFLU |
Common or Proper name | OSELTAMIVIR |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | OSELTAMIVIR |
Strength(s) | 6MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | Powder for Oral Suspension |
ATC code | J05AH |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-03-01 |
Actual start date | |
Estimated end date | 2018-03-01 |
Actual end date | 2018-02-28 |
Shortage status | Avoided shortage |
Updated date | 2018-02-28 |
Company comments | Supply replenished. No out of stock experienced. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2018-02-28 | French | Compare |
v13 | 2018-02-28 | English | Compare |
v12 | 2018-02-28 | English | Compare |
v11 | 2018-02-21 | French | Compare |
v10 | 2018-02-21 | English | Compare |
v9 | 2018-02-15 | French | Compare |
v8 | 2018-02-15 | English | Compare |
v7 | 2018-02-08 | French | Compare |
v6 | 2018-02-08 | English | Compare |
v5 | 2018-02-08 | French | Compare |
v4 | 2018-02-08 | French | Compare |
v3 | 2018-02-08 | English | Compare |
v2 | 2018-02-08 | French | Compare |
v1 | 2018-02-08 | English | Compare |
Showing 1 to 14 of 14